Sotac Pharmaceuticals Limited
Bookbuilding IPO · NSE
- Price band
- ₹105 - ₹111
- Lot size
- 1,200 shares
- Issue amount
- ₹33.3 cr
- Total subscription
- 1.6×
- Opens
- 29 Mar 2023
- Closes
- 3 Apr 2023
- Allotment
- 10 Apr 2023
- Listing
- 13 Apr 2023
Offer at a glance
Issue overview
- Issue size
- 30,00,000 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹1,26,000
- Fresh issue
- ₹33.3 cr
- Offer for sale
- ₹0 cr
- Registrar
- Kfin Technologies Limited
- Listing exchange
- NSE
- Maximum investment
- ₹1,33,200
- Issue type
- Bookbuilding IPO
- Shares before issue
- 80,50,000
- Shares after issue
- 1,10,50,000
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 1,200 | ₹1,33,200 |
| HNI | 2 | 2,400 | ₹2,66,400 |
Share reservation
Subscription & GMP
Subscription by category
Subscription figures are awaiting publication.
GMP history
Financial performance
Company financials
In Lakhs · Reported periods may include interim results.
Key performance indicators
| Metric | Values |
|---|---|
| EPS | 0 |
| ROE | 6.38 |
| ROCE | 19.03 |
| RONW | 0 |
| PRE IPO(PE) | 132.14 |
| POST IPO(PE) | 0 |
Values and labels as reported in the issue data.
Company information
Company profile
Incorporated in 2015, Sotac Pharmaceuticals Limited, part of the Gujarat-based SOTAC Group, is engaged in manufacturing pharmaceutical products for various marketers on a loan license and contract manufacturing basis. Serving over 162 corporate clients, the company operates primarily on a principal-to-principal model. Established in 2017, its manufacturing facility has an annual capacity of 90 crore tablets and 14 crore capsules. Backed by promoters with over 59 years of combined industry experience, Sotac Pharmaceuticals continues to expand and strengthen its presence in the pharmaceutical sector.
Promoters
Mr. Sharadkumar Dashrathbhai Patel
Mr. Dineshkumar Babulal Gelot
Mr. Vishalkumar Devrajbhai Patel
Mr. Chetankumar Bachubhai Patel
Mrs. Kiran Baldevbhai Jotania
Registrar & documents
Lead manager
Beeline Capital Advisors Private Limited
Registrar & contacts
Kfin Technologies Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
Plot No. PF-21, Nr. ACME Pharma, Opp. Teva Pharma Sanand GIDC-II, Sanand Ahmedabad - 382110
+91 90819 93300
[email protected]Company website ↗Understanding SOTAC IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.